Victory Capital Management’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
Other funds holding CMPX
Victory Capital Management's CMPX Position: Q3 2026 in Review
Victory Capital Management increased its Compass Therapeutics (CMPX) stake by 5.4% in Q3 2026, buying an estimated $1.65K and bringing the position to 15,606 shares worth $16.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2501.
Victory Capital Management first reported a position in CMPX in Q4 2023 and has held it in 11 quarters since. The position peaked at $76.8K in Q4 2025. 116 funds tracked by Wall St. Rank hold CMPX as of Q3 2026.
- Victory Capital Management held 15,606 shares of Compass Therapeutics worth $16.2K as of Q3 2026.
- Victory Capital Management bought 800 Compass Therapeutics shares in Q3 2026, an estimated $1.65K.
- Compass Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #2501 holding.
- Victory Capital Management first reported a position in Compass Therapeutics in Q4 2023 and has held it in 11 quarters since.
- Victory Capital Management's Compass Therapeutics position peaked at $76.8K in Q4 2025.
- 116 funds tracked by Wall St. Rank held Compass Therapeutics as of Q3 2026.
Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.